|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,887.00 JPY | +1.83% |
|
+2.43% | +25.27% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Drug Stores and Pharmacies | ||||||||||
Matsumoto Tokyo Group Business | - | 540B | 573B | 633B | 667B | |||||
Total Assets | - | 381B | 410B | 443B | 473B | |||||
CAPEX | - | -6.59B | -8.76B | - | -7.78B | |||||
D&A | - | 7.2B | 5.48B | 7.46B | 7.14B | |||||
Operating Income | - | 36.17B | 41.8B | 51.74B | 57.95B | |||||
Cocokara Fine Group Business | - | 183B | 376B | 387B | 391B | |||||
Total Assets | - | 395B | 383B | 376B | 364B | |||||
CAPEX | - | -2.63B | -7.28B | - | -2.68B | |||||
D&A | - | 5.74B | 11.31B | 12.05B | 11.9B | |||||
Operating Income | - | 5.31B | 19.35B | 21.8B | 23.8B | |||||
Retail - Others | 196B | - | - | - | - | |||||
Total Assets | 132B | - | - | - | - | |||||
CAPEX | -2.14B | - | - | - | - | |||||
D&A | 2.45B | - | - | - | - | |||||
Operating Income | 13.73B | - | - | - | - | |||||
Retail - Matsumotokiyoshi Co., Ltd. | 331B | - | - | - | - | |||||
Total Assets | 145B | - | - | - | - | |||||
CAPEX | -3.43B | - | - | - | - | |||||
D&A | 3.78B | - | - | - | - | |||||
Operating Income | 17.94B | - | - | - | - | |||||
General Management Services | ||||||||||
Management Support Business | 14.98B | 463B | 566B | 637B | 655B | |||||
Total Assets | 222B | 583B | 667B | 690B | 677B | |||||
CAPEX | -1.66B | -2.74B | -4.11B | - | -5.47B | |||||
D&A | 1.67B | 2.08B | 4.22B | 3B | 3.68B | |||||
Operating Income | -1.73B | -131M | 5.1B | 30.26B | 20.18B | |||||
Unallocated Adjustment | -368B | -456B | -563B | -634B | -652B | |||||
Total Assets | -221B | -701B | -772B | -785B | -801B | |||||
CAPEX | 114M | 49M | 292M | - | 29M | |||||
D&A | 619M | -148M | -169M | -132M | -116M | |||||
Operating Income | -541M | 56M | -3.97B | -28.09B | -19.86B | |||||
Pharmaceutical Product Distribution | ||||||||||
Wholesale Business - Others | 20.6B | - | - | - | - | |||||
Total Assets | 3.52B | - | - | - | - | |||||
CAPEX | -90M | - | - | - | - | |||||
D&A | 53M | - | - | - | - | |||||
Operating Income | 458M | - | - | - | - | |||||
Wholesale Business - Kiyoshi Matsumoto Holdings | 362B | - | - | - | - | |||||
Total Assets | 86.68B | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
D&A | 9M | - | - | - | - | |||||
Operating Income | 1.67B | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Japan | 557B | 730B | 951B | 1,023B | 1,062B | |||||
Total Assets | 369B | 657B | 688B | 725B | 713B | |||||
Interest Expense | -44M | -60M | -53M | -57M | -64M | |||||
Income Tax Expense | 11.05B | 15.02B | 24.14B | 28.63B | 28.88B | |||||
D&A | 8.58B | 14.86B | 20.84B | 22.37B | 22.6B | |||||
CAPEX | -5.27B | -10.97B | -16.75B | -13.21B | -8.83B | |||||
Gross Profit | 182B | 240B | 329B | 354B | 372B | |||||
Net Income | 21.57B | 34.59B | 40.54B | 52.35B | 54.68B | |||||
EBT | 32.62B | 49.63B | 64.91B | 81.25B | 83.89B | |||||
Operating Income | 31.53B | 41.41B | 62.28B | 75.7B | 82.08B |
- Stock Market
- Equities
- 3088 Stock
- Financials MatsukiyoCocokara & Co.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition